Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Yves Bikorimana: When Cancer Triggers Blood Clotting – Understanding Trousseau Syndrome
Yves Bikorimana/LinkedIn
Mar 19, 2026, 15:14

Yves Bikorimana: When Cancer Triggers Blood Clotting – Understanding Trousseau Syndrome

Yves Bikorimana, CEO at MedData – Rwanda and Lab Scientist at The University Teaching Hospital of Kigali – Chuk, shared a post on LinkedIn:

“When Cancer Triggers Blood Clotting: Understanding Trousseau Syndrome

Cancer – associated thrombosis is a critical yet sometimes under-recognized cause of thromboembolic events.

One classic example is Trousseau syndrome, a paraneoplastic condition first described by Armand Trousseau, in which cancer creates a hypercoagulable (pro-clotting) state.

How does this happen?

Malignancies can activate the coagulation system through several biological mechanisms:

  • Tumor cells release tissue factor and procoagulant microparticles
  • Mucin – producing tumors interact with platelets and selectins
  • Systemic inflammation increases thrombin generation

Clinical consequences may include:

  • Migratory thrombophlebitis
  • Recurrent venous thromboembolism
  • Arterial thrombosis and unexplained (cryptogenic) stroke

This condition is most commonly associated with cancers such as pancreatic, gastric, and lung malignancies.

Key takeaway for clinicians:

  • Unexplained or recurrent thrombosis – especially in unusual locations – should raise suspicion of an underlying (occult) malignancy.
  • Understanding cancer-associated hypercoagulability is essential for early diagnosis, accurate risk assessment, and improved patient management.”

Stay updated with Hemostasis Today.

Armand Trousseau Cancer Associated Thrombosis Health Hematology Hemostasis Hemostasis News Hemostasis Today Medicine thrombosis Trousseau syndrome Yves Bikorimana
NewsFeed